265 related articles for article (PubMed ID: 19715460)
1. Human papillomaviruses and the interferon response.
Beglin M; Melar-New M; Laimins L
J Interferon Cytokine Res; 2009 Sep; 29(9):629-35. PubMed ID: 19715460
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of human papillomaviruses in differentiating epithelia.
Longworth MS; Laimins LA
Microbiol Mol Biol Rev; 2004 Jun; 68(2):362-72. PubMed ID: 15187189
[TBL] [Abstract][Full Text] [Related]
3. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of the innate immune response by human papillomaviruses.
Hong S; Laimins LA
Virus Res; 2017 Mar; 231():34-40. PubMed ID: 27826042
[TBL] [Abstract][Full Text] [Related]
5. Roles for E1-independent replication and E6-mediated p53 degradation during low-risk and high-risk human papillomavirus genome maintenance.
Murakami I; Egawa N; Griffin H; Yin W; Kranjec C; Nakahara T; Kiyono T; Doorbar J
PLoS Pathog; 2019 May; 15(5):e1007755. PubMed ID: 31083694
[TBL] [Abstract][Full Text] [Related]
6. Human papillomaviruses and cell signaling.
McCance DJ
Sci STKE; 2005 Jun; 2005(288):pe29. PubMed ID: 15956361
[TBL] [Abstract][Full Text] [Related]
7. KLF13 regulates the differentiation-dependent human papillomavirus life cycle in keratinocytes through STAT5 and IL-8.
Zhang W; Hong S; Maniar KP; Cheng S; Jie C; Rademaker AW; Krensky AM; Clayberger C
Oncogene; 2016 Oct; 35(42):5565-5575. PubMed ID: 27041562
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus proteins as prospective therapeutic targets.
Pang CL; Thierry F
Microb Pathog; 2013 May; 58():55-65. PubMed ID: 23164805
[TBL] [Abstract][Full Text] [Related]
9. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis.
Wei T; Grace M; Uberoi A; Romero-Masters JC; Lee D; Lambert PF; Munger K
mBio; 2021 Aug; 12(4):e0227721. PubMed ID: 34465025
[TBL] [Abstract][Full Text] [Related]
10. Control of interferon signaling in human papillomavirus infection.
Koromilas AE; Li S; Matlashewski G
Cytokine Growth Factor Rev; 2001; 12(2-3):157-70. PubMed ID: 11325599
[TBL] [Abstract][Full Text] [Related]
11. Transcription Properties of Beta-HPV8 and HPV38 Genomes in Human Keratinocytes.
Rehm TM; Straub E; Forchhammer S; Leiter U; Iftner T; Stubenrauch F
J Virol; 2022 Dec; 96(23):e0149822. PubMed ID: 36394329
[TBL] [Abstract][Full Text] [Related]
12. Roles of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer.
Taghizadeh E; Jahangiri S; Rostami D; Taheri F; Renani PG; Taghizadeh H; Gheibi Hayat SM
Curr Protein Pept Sci; 2019; 20(9):926-934. PubMed ID: 31244421
[TBL] [Abstract][Full Text] [Related]
13. Human papillomaviruses and their role in cervical cancer.
Dell G; Gaston K
Cell Mol Life Sci; 2001 Nov; 58(12-13):1923-42. PubMed ID: 11766888
[TBL] [Abstract][Full Text] [Related]
14. The role of human papillomaviruses in oncogenesis.
Mighty KK; Laimins LA
Recent Results Cancer Res; 2014; 193():135-48. PubMed ID: 24008297
[TBL] [Abstract][Full Text] [Related]
15. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation.
Dust K; Carpenter M; Chen JC; Grant C; McCorrister S; Westmacott GR; Severini A
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016386
[TBL] [Abstract][Full Text] [Related]
17. The pathobiology and mechanisms of infection of HPV.
Wood NH; Khammissa RA; Chikte UM; Meyerov R; Lemmer J; Feller L
SADJ; 2010 Apr; 65(3):124-6. PubMed ID: 20496845
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the properties of the E6 and E7 genes of low- and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1.
Schmitt A; Harry JB; Rapp B; Wettstein FO; Iftner T
J Virol; 1994 Nov; 68(11):7051-9. PubMed ID: 7933087
[TBL] [Abstract][Full Text] [Related]
19. Post-Transcriptional Regulation of KLF4 by High-Risk Human Papillomaviruses Is Necessary for the Differentiation-Dependent Viral Life Cycle.
Gunasekharan VK; Li Y; Andrade J; Laimins LA
PLoS Pathog; 2016 Jul; 12(7):e1005747. PubMed ID: 27386862
[TBL] [Abstract][Full Text] [Related]
20. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity.
Hebner CM; Laimins LA
Rev Med Virol; 2006; 16(2):83-97. PubMed ID: 16287204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
